Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses

Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses

Open Access statistics for Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, France, covering academic research published from 2000 to 2023.

Open Access statistics for Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, France, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

59%


Total
Publications

278


Total Open
Publications

163


Total
Citations

11K


Open Access
Percentage

59%


Total
Publications

278


Total Open
Publications

163


Total
Citations

11K

Website

download

Breakdown

7% 39% 13% 41%

Publisher Open

7%

Both

39%

Other Platform Open

13%

Closed

41%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022242628Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

48%OA Journal

OA Journal 48%

62

Hybrid 25%

32

No Guarantees 27%

34

Other Platform Open

Domain 64%

91

Institution 60%

86

Other Internet 26%

37

Public 15%

21

Preprint 8%

11

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
91
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
54
Europe PMC
Domain
54
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
37
Le Centre pour la Communication Scientifique Directe - HAL - Université de Nantes
Institution
32
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
24
Le Centre pour la Communication Scientifique Directe - HAL - memSIC
Other Internet
18
Semantic Scholar
Public
17
Figshare
Public
16
DOI
Other Internet
10
1 / 8

Data updated 7 October 2024

Share

Share

Share